Dashboard
High Management Efficiency with a high ROE of 16.85%
Company has a low Debt to Equity ratio (avg) at 0 times
Flat results in Mar 26
Stock is technically in a Bullish range
With ROE of 13.4, it has a Very Expensive valuation with a 9.1 Price to Book Value
High Institutional Holdings at 37.6%
Stock DNA
Industrial Products
INR 26,842 Cr (Small Cap)
55.00
50
0.90%
-0.12
16.43%
9.12
Total Returns (Price + Dividend) 
Latest dividend: 36 per share ex-dividend date: Jul-25-2025
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Jun-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we attach herewith copies of advertisements published in todays newspapers titled - Notice to Shareholders - Investor Education and Protection Fund Launch of Second 100 - Day Campaign - Saksham Niveshak and Special Window for Transfer and Demat of Physical Securities. The advertisement copies are also available on the Companys website at www.timken.com/en-in. Kindly request you to take this on record.
CIVIL SUIT BEFORE HIGH COURT OF CALCUTTA
30-May-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you about civil suit filed by Artech International Private Limited against the Company before High Court of Calcutta. Artech International Private Limited was appointed as Distributor of the Company through execution of Distributor Agreement(s). The Company vide notice dated 8 May 2026 terminated Distributor Agreement(s) w.e.f. 7 July 2026 by giving 60 days notice. Artech International Private Limited has filed civil suit before High Court of Calcutta challenging termination notice dated 8 May 2026 and alternatively claimed damages to the tune of approx. Rs 107.86 crore. The matter was heard on 29 May 2026 by vacation bench of High Court of Calcutta. The Company has raised the point about maintainability of civil suit. The Company at this stage does not expect any financial implications. You are requested to take note of the above.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
22-May-2026 | Source : BSEPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we attach herewith transcript of Post Results Conference Call Q4 FY 2025-26 held on Tuesday 19 May 2026. A copy of the same will also be available on the website of the Company.
Corporate Actions 
No Upcoming Board Meetings
Timken India Ltd has declared 360% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 28 Schemes (25.88%)
Held by 127 FIIs (6.96%)
Timken Singapore Pte Ltd (51.05%)
Hdfc Mutual Fund - Hdfc Mid-cap Fund (7.94%)
8.41%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 40.39% vs -1.11% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 210.51% vs -44.28% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.94% vs 9.79% in Sep 2024
Growth in half year ended Sep 2025 is 3.99% vs 1.68% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 6.26% vs 9.75% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -6.53% vs 3.93% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 8.63% vs 8.19% in Mar 2025
YoY Growth in year ended Mar 2026 is -10.97% vs 14.09% in Mar 2025